Drug toxicity - Revision history

Michael: /* General principles */

2018-03-22T03:20:06Z

General principles

← Older revision		Revision as of 03:20, 22 March 2018
Line 11:		Line 11:
	#* Improvement with removal of exposure.		#* Improvement with removal of exposure.
	#* Pathologic pattern matches with toxin.		#* Pathologic pattern matches with toxin.
	#* Drug.		#* Drug/toxin detected within individual.

	=Site specific=		=Site specific=

2018-03-22T03:05:17Z

General principles

← Older revision		Revision as of 03:05, 22 March 2018
Line 4:		Line 4:

	=General principles=		=General principles=
	~~Drug~~ reaction should be considered if there is:		A drug/toxin reaction should be considered if there is:
	# Ingestion ~~of drug~~.		# Ingestion/exposure.
	# ~~Temporal~~ relation ~~must be compatible~~.		# An appropriate temporal relation.
	# ~~Empirical~~ correlation between the drug/toxin and the pattern.		# An empirical correlation between the drug/toxin and the pattern.
	#* Worsening with re-challenge.		#* Worsening with re-challenge.
	#* Improvement with removal of exposure.		#* Improvement with removal of exposure.

2018-03-22T03:02:45Z

General principles

← Older revision		Revision as of 03:02, 22 March 2018
Line 4:		Line 4:

	=General principles=		=General principles=
	Drug reaction should be considered if:		Drug reaction should be considered if there is:
	# Ingestion of drug.		# Ingestion of drug.
	# Temporal relation must be compatible.		# Temporal relation must be compatible.
Line 11:		Line 11:
	#* Improvement with removal of exposure.		#* Improvement with removal of exposure.
	#* Pathologic pattern matches with toxin.		#* Pathologic pattern matches with toxin.
	#* Drug.		#* Drug.

	=Site specific=		=Site specific=

2018-03-22T03:02:03Z

← Older revision		Revision as of 03:02, 22 March 2018
Line 2:		Line 2:

	This article covers a few of the distinctive histomorphologic pattern and links to other articles that deal with specific organ systems.		This article covers a few of the distinctive histomorphologic pattern and links to other articles that deal with specific organ systems.

			=General principles=
			Drug reaction should be considered if:
			# Ingestion of drug.
			# Temporal relation must be compatible.
			# Empirical correlation between the drug/toxin and the pattern.
			#* Worsening with re-challenge.
			#* Improvement with removal of exposure.
			#* Pathologic pattern matches with toxin.
			#* Drug.

	=Site specific=		=Site specific=

2014-09-05T15:44:19Z

Site specific

← Older revision		Revision as of 15:44, 5 September 2014
Line 6:		Line 6:
	==Liver drug toxicity==		==Liver drug toxicity==
	*[[Drug-induced liver disease]].		*[[Drug-induced liver disease]].

			==Stomach==
			*[[Reactive gastropathy]].

			==Small bowel==
			*[[Small bowel diaphragm disease]].

	=Specific drugs=		=Specific drugs=

2014-09-05T15:41:17Z

← Older revision		Revision as of 15:41, 5 September 2014
Line 3:		Line 3:
	This article covers a few of the distinctive histomorphologic pattern and links to other articles that deal with specific organ systems.		This article covers a few of the distinctive histomorphologic pattern and links to other articles that deal with specific organ systems.

	=Site=		=Site specific=
	==Liver drug toxicity==		==Liver drug toxicity==
	*[[Drug-induced liver disease]].		*[[Drug-induced liver disease]].

2014-09-05T15:40:01Z

← Older revision		Revision as of 15:40, 5 September 2014
Line 3:		Line 3:
	This article covers a few of the distinctive histomorphologic pattern and links to other articles that deal with specific organ systems.		This article covers a few of the distinctive histomorphologic pattern and links to other articles that deal with specific organ systems.

	=Liver drug toxicity=		=Site=
			==Liver drug toxicity==
	*[[Drug-induced liver disease]].		*[[Drug-induced liver disease]].

	=~~Luminal gastrointestinal pathology~~=		=Specific drugs=
	==Sodium polystyrene sulfonate==		==Sodium polystyrene sulfonate==
	:[[AKA]] ''Kayexalate'' (trade name).		:[[AKA]] ''Kayexalate'' (trade name).
Line 21:		Line 22:
	</gallery>		</gallery>

	~~=Specific drugs=~~
	==Proton pump inhibitor==		==Proton pump inhibitor==
	{{Main\|Proton pump inhibitor effect}}		{{Main\|Proton pump inhibitor effect}}

2014-09-05T15:38:58Z

2014-09-05T15:35:32Z

Nonsteroidal anti-inflammatory drugs

← Older revision		Revision as of 15:35, 5 September 2014
Line 26:		Line 26:

	==Nonsteroidal anti-inflammatory drugs==		==Nonsteroidal anti-inflammatory drugs==
	{{Main\|~~Nnonsteroidal~~ anti-inflammatory drugs}}		{{Main\|Nonsteroidal anti-inflammatory drugs}}

	==Oral contraceptive pill==		==Oral contraceptive pill==

2014-09-05T15:35:23Z

Nonsteroidal anti-inflammatory drugs

← Older revision		Revision as of 15:35, 5 September 2014
Line 26:		Line 26:

	==Nonsteroidal anti-inflammatory drugs==		==Nonsteroidal anti-inflammatory drugs==
	*{{Main\|Nnonsteroidal anti-inflammatory drugs}}		{{Main\|Nnonsteroidal anti-inflammatory drugs}}

	==Oral contraceptive pill==		==Oral contraceptive pill==

← Older revision		Revision as of 15:38, 5 September 2014
Line 31:		Line 31:
	{{Main\|Oral contraceptive pill}}		{{Main\|Oral contraceptive pill}}

	=~~See also~~=		==Minocycline==
	*[[Minocycline associated thyroid pigmentation]].		*[[Minocycline associated thyroid pigmentation]].

			==Spironolactone==
	*[[Spironolactone bodies]].		*[[Spironolactone bodies]].

			=See also=
			*[[Basics]].

	=References=		=References=